Replies to post #160380 on Anavex Life Sciences Corp (AVXL)

[F1ash]

What is/was the consensus of the 9,000,000 shares traded on 7/3?
I don't recall that there was a lot of discussion about this

A major development occurred on 7/3 imho.

“NEW YORK – July 3, 2018 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that the Company has received approval by the Australian Human Research Ethics Committee to initiate its Phase 2b/3 double-blind, randomized, placebo-controlled, 48-week safety and efficacy trial of ANAVEX®2-73 for the treatment of early Alzheimer’s disease. “

https://www.anavex.com/anavex-life-sciences-receives-approval-to-initiate-phase-2b-3-clinical-trial-of-anavex2-73-for-the-treatment-of-early-alzheimers-disease/


Too bad the Cantor agreement wasn’t in effect at the time. Probably a missed opportunity imho.



“On July 6, 2018, Anavex Life Sciences Corp. (the “Company”) entered into a Controlled Equity Offering SM Sales Agreement (the “Sales Agreement”) with Cantor Fitzgerald & Co., as agent (“Cantor Fitzgerald”), pursuant to which the Company may offer and sell shares of common stock, par value $0.001 per share (the “Shares”), for aggregate gross sale proceeds of up to $50,000,000 from time to time through Cantor Fitzgerald (the “Offering”).

http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=12851999&RcvdDate=7/6/2018&CoName=ANAVEX%20LIFE%20SCIENCES%20CORP.&FormType=8-K&View=html